STATEN ISLAND, N.Y., Oct. 15, 2019 /PRNewswire/ -- Chelsea Financial Services (Chelsea) Representative John Pirozzi will participate in the TCS New York City Marathon on November 3, 2019 to benefit the Boomer Esiason Foundation and Cystic Fibrosis Research.Chelsea Company President,

SAN FRANCISCO, Oct. 15, 2019 /PRNewswire/ -- About two-thirds (66%) of women who have miscarried blame themselves for losing the pregnancy. And despite the fact that the majority of miscarriages are the result of chromosomal abnormalities, 59% of women still mistakenly believe "stress" can cause a miscarriage; 28% mistakenly cite "intense exercise," and 27% cite "lifting

BOISE, Idaho, Oct. 15, 2019 /PRNewswire/ -- NeuralSync™ has released a ground-breaking audio compilation augmented with Zero-point energy for individuals interested in self-empowerment and non-medical approaches to wellbeing. Unlike traditional sound therapy, NeuralSync™ audios are embedded with scalar waves to produce a potent synergistic effect on the liste

DALLAS, Oct. 15, 2019 /PRNewswire/ -- Medecision, an integrated health management solutions company, and more than 25 thought leaders from across the healthcare and technology sectors, will host

TULSA, Okla., Oct. 15, 2019 /PRNewswire/ -- As one of the largest trade shows for the health and nutrition industry, SupplySide West brings together some of the top performers and manufacturers in the nutraceutical industry for networking and discovery. In fact, nearly 17,000 attendees and 1,300 exhibitors will converge on Las Vegas to at

WEST PALM BEACH, Fla., Oct. 15, 2019 /PRNewswire/ -- Bravado Health today announced that Christopher Lazzara has joined the company's board of directors. Lazzara was CEO of Neptune Research LLC until their recent merger with Clock Spring. He is now a board member of the combined Clockspring-NRI corporation.

BALTIMORE, Oct. 15, 2019 /PRNewswire/ -- Tissue Analytics is an AI-powered software solution that allows providers to monitor and automatically measure wound healing

WASHINGTON, Oct. 15, 2019 /PRNewswire/ -- The Homeowners Consumer Center says, "In early 2009 tens of thousands of homeowners/families in Florida

SAN FRANCISCO, Oct. 15, 2019 /PRNewswire/ -- OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, today announced that Nikhilesh N. Singh, Ph.D., Founder and Chief Scientific Officer, will present at the BIO Investor Forum, being held October 22-23, 2019,

NEW YORK, Oct. 15, 2019 /PRNewswire/ -- The Mesothelioma Victims Center says, "We are passionate advocates for people with mesothelioma an